Skyscape Web Viewer : DrDrugs®: Drug Guide for Physicians : Pharmacologic Index

View All
macrolides azithromycin erythromycin clarithromycin fidaxomicin
mast cell stabilizers
meglitinides nateglinide repaglinide
melanocortin receptor agonists afamelanotide setmelanotide bremelanotide
melatonin receptor agonists tasimelteon ramelteon
microsomal transfer protein inhibitors
minerals electrolytes fluoride supplements magnesium sulfate (parenteral)
monamine oxidase inhibitors isocarboxazid tranylcypromine phenelzine
monoamine oxidase type b inhibitors safinamide rasagiline selegiline
monobactams aztreonam aztreonam/avibactam
monoclonal antibodies adalimumab alirocumab alemtuzumab amivantamab atezolizumab axatilimab belimumab bevacizumab blinatumomab caplacizumab certolizumab concizumab crovalimab daratumumab/hyaluronidase denosumab donanemab durvalumab elranatamab emicizumab erenumab evolocumab faricimab galcanezumab golimumab ibritumomab inebilizumab ipilimumab lanadelumab lecanemab margetuximab mogamulizumab naxitamab nirsevimab obinutuzumab ocrelizumab/hyaluronidase anifrolumab avelumab basiliximab benralizumab bimekizumab burosumab cemiplimab cetuximab crizanlizumab daratumumab datopotamab deruxtecan dinutuximab dostarlimab elotuzumab emapalumab eptinezumab evinacumab fam-trastuzumab deruxtecan fremanezumab gemtuzumab ozogamicin guselkumab idarucizumab infliximab isatuximab lebrikizumab loncastuximab tesirine mepolizumab natalizumab necitumumab nivolumab ocrelizumab ofatumumab omalizumab pertuzumab polatuzumab vedotin ravulizumab risankizumab rituximab/hyaluronidase satralizumab tafasitamab teplizumab tezepelumab trastuzumab tremelimumab ustekinumab vilobelimab pembrolizumab pertuzumab/trastuzumab/hyaluronidase ranibizumab reslizumab rituximab rozanolixizumab secukinumab talquetamab teprotumumab tildrakizumab trastuzumab/hyaluronidase ublituximab vedolizumab
Mechanistic target of rapamycin kinase inhibitors
metabolic inhibitors
mineralocorticoid receptor antagonists non steroidal
monoclonal anti-toxins raxibacumab obiltoxaximab
muscarinic agonists